Academy Exchange

 View Only
  • 1.  CMS requesting public comment on Apretude being covered under CMS rule for PrEP

    Posted 26 days ago
    Edited by Eric Farmer 26 days ago
    ViiV as officially requested their product, Apretude, be included for coverage of PrEP for individuals at high risk of HIV acquisition since PrEP carries a "Grade A" recommendation from the USPSTF. Public comment is requested for its consideration. CMS is particularly interested in comments that include scientific evidence. A link to the ViiV letter as well as a link to instructions on submitting comments can be found on the webpage. 

    NCA - Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection (CAG-00464N) - Tracking Sheet (cms.gov)


    ------------------------------
    Eric Farmer
    Indiana University Health
    IndianapolisIN
    ------------------------------


  • 2.  RE: CMS requesting public comment on Apretude being covered under CMS rule for PrEP

    Posted 6 days ago
    Thank you so much for this information, Eric! My organization has submitted public comment.

    ------------------------------
    Kevin Aloysius
    HoustonTX
    ------------------------------